Expression and Clinical Significances of c-myb and Bax Proteins in Endometrial Carcinoma

FENG Yu-kuan, LÜ Lin, ZHANG Ya-qing. et al

Abstract

To study the expressions of c-myb and Bax proteins and their relationships with clinic-pathological characteristics in endometrial carcinoma. Methods The expressions of c-myb and Bax protein were detected by immunohistochemistry in 42 normal endometrial tissues and 68 endometrial carcinoma tissues. Apoptosis index was detected by TUNEL technique. Results The positive expression rates of c-myb and Bax in endometrial carcinoma were significantly higher than those in normal endometrial tissues (P<0.05). The expressions of c-myb and Bax in low differentiated endometrial carcinoma were higher than those in high and middle differentiated endometrial carcinoma (P<0.05). The expressions of c-myb and Bax in stage Ⅲ and stage Ⅳ endometrial carcinoma were higher than those in stageⅠand stgeⅡ endometrial carcinoma (P<0.05). Apoptosis index in endometrial carcinoma was higher than that in normal endometrial carcinoma.The poorer the cellular differentiation was, the higher the apoptosis index was. There was positive correlation between the expression of Bax and apoptosis index (P<0.05), but no correlation between the expression of c-myb and apoptosis index (P>0.05). Conclusion Endometrial carcinoma has high expression of c-myb and Bax, and the expression status of both c-myb and Bax may be related to the malignant degree and prognosis of endometrial carcinoma.

 

Keywords: c-myb, Bax, Endometrial carcinoma 

 

Full Text:

PDF


References


Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer,2008;8(7):523-534.

Sala A. c-MYB and TGFj3: EMTf s dynamic duo in breast cancer. Cell Cycle, 2012; 11 (1): 17. doi: 10. 4161/cc. 11. 1.

Thompson МА, Ramsay RG. Myb; an old oncoprotein with new roles. Bioessays. 1995; 17(4) ;341-350.

Lu H, Wang Y. Huang Y. et al. Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma. Clin Transl Oncol, 2013; 15 ( 10 ) ; 796-801.

Husain M, Jiang L. See V, et al. Regulation of vascular smooth muscle cell proliferation by plasma membrane Ca2+- ATPase. Am J Physiol,1997;272(6 Pt 1) :C1947-C1959.

Ye P. Zhao L, McGirr С, et al. MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo. Cancer Lett,2014;343( 1):98-106.

Sarvaiya PJ . Schwartz JR, Hernandez CP,et al. Role of c-Myb in the survival of pre Id-cell acute lymphoblastic leukemia and leukemogenesis. Am J Hematol,2012;87( 10) ;969-976.

Cai W, Li Q, Yang Z, et al. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance. Clin Transl Oncol,2013; 15(10):818-824.

Ntranos А, HallO, Robinson DP. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. J Neuroimmunol,2014;270(1-2): 13-21.

Kockx M. Guo DL. Traini M. Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 ( ABCA1 )-independent pathway.J Biol Chem,2009;284(36):24144-24154.

Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation; past, present and future. Semin Nephrol, 2000;(2):108-125.

Opelz G, Dohler В, Opelz G. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Transplantation. 2009;87(6);795-802.


Refbacks

  • There are currently no refbacks.